Tafamidis and its stabilizing effects on transthyretin tetramers, the heart and eventually, scientific evidence

European Heart Journal - Cardiovascular Imaging

2 May 2022

Organised by:

Read full article

Contributors

René Rettl

René Rettl

Author

Diana Bonderman

Diana Bonderman

Author

Favoriten Clinic Vienna , Austria

You may be interested in

Congress Presentation

Relationship of tafamidis binding site occupancy, transthyretin stabilization, and disease modification in tafamidis treated transthyretin amyloid cardiomyopathy patients

27 August 2022

Congress Presentation

Evolving the understanding of TTR's role in health and disease

31 August 2025

Congress Presentation

Acoramidis produces near-complete TTR stabilization in blood samples from patients with variant transthyretin amyloidosis that is greater than that achieved with tafamidis

26 August 2023

Congress Presentation

Two-year cardiac follow-up of transthyretin amyloid deposition in surgical specimens from carpal tunnel syndrome and rotator cuff tear cases

31 August 2025

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources